Training Adaptations With and Without Ventilatory Training Device

This study assesses the impact of a ventilatory training device, similar to a sports mouth guard worn during exercise, on various performance outcomes. The main questions it aims to answer are:

• Does the device improve fitness parameters: high-intensity functional training, anaerobic capacity, anaerobic peak and mean power output, maximal oxygen uptake, ventilatory threshold, and blood lactate responses to training?
• Does the device improve spirometry measures?

Researchers will compare 6 weeks of training with the ventilatory training device to those without the training device.

Participants will:

• Take part in a total of 8 weeks of study-related activity.
• Complete six total one- to two-hour pre- and post-testing sessions, which include a maximal oxygen uptake test, high-intensity functional training, body composition, spirometry, anaerobic power and capacity testing.
• Complete six weeks of 45-minute high-intensity functional training, three days per week.

Inclusion criteria

• Males and females between the ages of 18 and 35 (inclusive) who participate in at least 150 minutes per week of physical activity.
• Have not participated in HIFT training in the last 6 months.
• Provided written and dated informed consent to participate in the study.
• In good health as determined by medical history and is cleared for exercise.
• Participant will be asked about dietary supplementation use within the past 6 months.

• If participant began taking a supplement within the past month, subject will be asked to discontinue supplement use followed by a 2-week washout prior to participation.
• In all other cases, we will request that participant maintain supplement use.

Exclusion criteria

• Any musculoskeletal injuries that would prevent exercising.
• Any metabolic disorder including known electrolyte abnormalities, diabetes, uncontrolled thyroid disease, adrenal disease or hypogonadism.
• Any inborn error of metabolism.
• History of hepatorenal, musculoskeletal, autoimmune, or neurologic disease.
• Participants with a personal history of heart disease, high blood pressure (systolic >140 mm Hg & diastolic >90 mm Hg),
• Participants who are pregnant, planning to become pregnant, or lactating.